Disruption of HPV16-E7 by CRISPR/Cas system induces apoptosis and growth inhibition in HPV16 positive human cervical cancer cells

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Hu, Zheng ^a   Yu, Lan ^a   Zhu, Da ^a   Ding, Wencheng ^a   Wang, Xiaoli ^a   Zhang, Changlin ^a   Wang, Liming ^a   Jiang, Xiaohui ^a   Shen, Hui ^a   He, Dan ^a   Li, Kezhen ^a   Xi, Ling ^a   Ma, Ding ^a   Wang, Hui ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GUIDE RNA; PROTEIN E7; RETINOBLASTOMA PROTEIN; VIRUS DNA; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CERVICAL CANCER CELL LINE; CONTROLLED STUDY; CRISPR CAS SYSTEM; DNA DAMAGE; DOWN REGULATION; EMBRYO; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IN VITRO STUDY; PAPILLOMAVIRUS INFECTION; UPREGULATION; UTERINE CERVIX CANCER; ANTAGONISTS AND INHIBITORS; CELL PROLIFERATION; FEMALE; GENETICS; HEK293 CELL LINE; PATHOGENICITY; PATHOLOGY; UTERINE CERVIX TUMOR; VIROLOGY;

APOPTOSIS; CELL PROLIFERATION; CRISPR-CAS SYSTEMS; FEMALE; HEK293 CELLS; HUMAN PAPILLOMAVIRUS 16; HUMANS; PAPILLOMAVIRUS E7 PROTEINS; UTERINE CERVICAL NEOPLASMS;

EID: 84923561654     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/612823     Document Type: Article

References (19)

1. E. P. Armstrong and D. Pharm, "Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types, " Journal of Managed Care Pharmacy, vol. 16, no. 3, pp. 217-230, 2010.
2. G. M. Clifford, J. S. Smith, and M. Plummer, "Human papillomavirus types in invasive cervical cancer worldwide: a metaanalysis, " British Journal of Cancer, vol. 88, no. 1, pp. 63-73, 2003.
3. C. Talora, D. C. Sgroi, and C. P. Crum, "Specific downmodulation of Notch1 signaling in cervical cancer cells isrequired for sustained HPV-E6/E7 expression and late steps of malignant transformation, " Genes & Development, vol. 16, no. 17, pp. 2252-2263, 2002.
4. C. J. Lee, E. J. Suh, H. T. Kang et al. , "Induction of senescencelike state and suppression of telomerase activity through inhibition of HPV E6/E7 gene expression in cells immortalized by HPV16 DNA, " Experimental Cell Research, vol. 277, no. 2, pp. 173-182, 2002.
5. C. H. Chung and M. L. Gillison, "Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications, " Clinical Cancer Research, vol. 15, no. 22, pp. 6758-6762, 2009.
6. R. Barrangou, C. Fremaux, H. Deveau et al. , "CRISPR provides acquired resistance against viruses in prokaryotes, " Science, vol. 315, no. 5819, pp. 1709-1712, 2007.
7. I. Katic and H. Grohans, "Targeted heritable mutation and gene conversion by Cas9-CRISPR in Caenorhabditis elegans, " Genetics, vol. 195, no. 3, pp. 1173-1176, 2013.
8. W. Y. Hwang, Y. Fu, D. Reyon et al. , "Efficient genome editing in zebrafish using a CRISPR-Cas system, " Nature Biotechnology, vol. 31, no. 3, pp. 227-229, 2013.
9. P. Mali, L. Yang, and K. M. Esvelt, "RNA-guided human genome engineering via Cas9, " Science, vol. 339, no. 6121, pp. 823-826, 2013.
10. E. Heidenreich, R. Novotny, B. Kneidinger et al. , "Nonhomologous end joining as an important mutagenic process in cell cycle-arrested cells, " The EMBO Journal, vol. 22, no. 9, pp. 2274-2283, 2003.
11. M. S. Bhakta and D. J. Segal, "The generation of zinc finger proteins by modular assembly, " Methods in Molecular Biology, vol. 649, pp. 3-30, 2010.
12. H. J. Kimand H. J. Lee, "Targeted genome editing in human cells with zinc finger nucleases constructed via modular assembly, " Genome Research, vol. 19, no. 7, pp. 1279-1288, 2009.
13. H. zur Hausen, "Papillomaviruses and cancer: from basic studies to clinical application, " Nature Reviews Cancer, vol. 2, no. 5, pp. 342-350, 2002.
14. A. L. Jonson, L. M. Rogers, S. Ramakrishnan et al. , "Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer, " Gynecologic Oncology, vol. 111, no. 2, pp. 356-364, 2008.
15. D. Castanotto and J. J. Rossi, "The promises and pitfalls of RNAinterference-based therapeutics, " Nature, vol. 457, no. 7228, pp. 426-433, 2009.
16. K. Rothkamm, I. Krüger, L. H. Thompson, and M. Lobrich, "Pathways of DNA double-strand break repair during the mammalian cell cycle, " Molecular and Cellular Biology, vol. 23, no. 16, pp. 5706-5715, 2003.
17. Y. Fu, J. A. Foden, and C. Khayter, "High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells, " Nature Biotechnology, vol. 31, no. 9, pp. 822-826, 2013.
18. C. Mussolino and T. Cathomen, "RNAguides genome engineering, " Nature Biotechnology, vol. 31, no. 3, pp. 208-209, 2013.
19. F. A. Ran, P. D. Hsu, C. Y. Lin et al. , "Double nicking by RNAguided CRISPR Cas9 for enhanced genome editing specificity, " Cell, vol. 154, no. 6, pp. 1380-1389, 2013.